• CONCLUSION: There is poor agreement of measurements among systems. AngioVue provides images with the highest vessel valid visibility and the fewest motion artifacts. AngioPlex achieves the shortest acquisition.
INTRODUCTION
O ptical coherence tomography angiography (OCTA) is the most important imaging innovation in ophthalmology in recent years. In order to demonstrate normal and pathologic vascularization, it extracts movement signals from moving particles in blood lumen, which are mainly erythrocytes, by comparing serial optical coherence tomography (OCT) B-scans, and it obtains a numerical value named voxel (portmanteau of "volume" and "pixel") which estimates the reflectivity of tiny loci on a selected region of retina by using different algorithms. OCTA, a three-dimensional functional OCT extension, is then generated based on the aggregation of voxels [1] [2] [3] [4] [5] . In Fourier domain OCT (FD-OCT) systems, covering spectral domain OCT (SD-OCT), and swept-source OCT (SS-OCT) [6] , the OCT signals contain both magnitude and phase information after Fourier transformation. To contrast blood flow, algorithms could be based on phase, magnitude, or both phase and magnitude of OCT signals [7] [8] .
Common OCTA algorithms include phase variance, speckle variance, correlation mapping, complex difference, splitspectrum amplitude decorrelation angiography (SSADA), optical microangiography (OMAG), OCT angiography ratio analysis (OCTARA), full-spectrum probabilistic approach, full-spectrum amplitude-decorrelation angiography (FSADA), phase-resolved doppler OCT (PRD-OCT), and ultra-high speed SS-OCT angiography with VISTA (UHS-OCTA) [9] [10] [11] [12] [13] [14] . With advances in technology, OCTA shows at least equivalence to dye-injected angiography in showing important vascular detail [15] .
Compared to traditional fluorescein angiography, the advantages of OCTA are obvious. It is non-invasive angiography without dye injection, and it is less time-consuming and easier to perform. It could be repeated at any time during follow-up visits, before, and after treatment. The results of OCTA are generally displayed as "en face" frontal sections (C-scans), and it gives the possibility to display and analyze selectively superficial to deep retinal capillary plexuses and choroidal capillaries [8, 16] . However, OCTA has limitations with recording vascular filling time, detecting vascular leakage, and demonstrating vasculature in the peripheral fields. Patients suffering significant changes in blood composition such as hyperleukocytosis in leukemia may also receive inaccurate OCTA results [17] [18] .
As the OCTA image is derived from signals generated intrinsically from repeated scans of tissue, image defects and anomalies in visual representations, are known as artifacts. Artifacts have a variety of causes including OCTA image acquisition, intrinsic properties of the eye, eye motion, or image processing and display. Among artifacts, motion artifacts are the most common and easily recognizable, and they appear as end-to-end lines in the axial directions, showing significant difference and poor correlation with neighboring scan lines [5, 19] . [11, 13, [20] [21] [22] [23] . [10] [11] [12] [13] [14] 23] . These systems use different acquisition, saving, and analysis processes. Generally, superficial retinal layer (SRL), deep retinal layer (DRL), outer retinal layer (ORL)/avascular slab, as well as choriocapillaris layer are segmented based on internal limiting membrane (ILM), inner plexiform layer (IPL), outer plexiform layer (OPL), retinal pigment epithelium (RPE), or Bruch's membrane (BM). Small deviations exist even in default layer segmentation. On account of these differences, the evaluation of OCTA is essential. Several studies have compared different OCTA systems, while certain quantitative methods, which can be widely used, are still lacking [14, 19, 24] . The aim of our study was to quantitatively compare the clinical performance of five different OCTA systems: AngioVue, AngioPlex, Spectralis OCTA, AngioScan, and SS OCT Angio. We compared them in terms of image quality and acquisition time, in a real-world complete examination.
Currently

SUBJECTS AND METHODS Subjects
In this cross-sectional study, 27 right eyes of 27 healthy subjects underwent OCTA examination in the Department of Ophthalmology of Shanghai General Hospital Affiliated to Shanghai Jiao Tong University from January 9, 2017 to January 31, 2017. This study was approved by the Institutional Review Board and Ethics Committee of Shanghai General Hospital and adhered to the tenets of the Declaration of Helsinki. Written informed consent was obtained from all subjects. The exclusion criteria are listed as follows: subjects less than 18 years old; best-corrected visual acuity (BCVA) less than 20/20; spherical equivalent refraction less than -6.00 diopters (D) or more than 6.00 D; intraocular pressure more than 21 mm Hg; opacity of refractive media; xerophthalmia; poor fixation and unconsciousness; active and suspected ocular pathology; history of OCTA examination, and history of ophthalmic surgery. Before inclusion, a complete ophthalmologic examination was performed on all eyes, including slit-lamp microscopy (both anterior and posterior segment with dilated pupil), non-contact tonometry and refraction. Instruments and Scan Patterns Technical details from AngioVue, AngioPlex, SS OCT Angio, Spectralis OCTA, and AngioScan system are displayed in Figure 1 and Table 1 [11 -14,23] . All eyes were measured without dilation using the all five of the OCTA systems. The 3×3 and 6×6 mm 2 Acquisition time were recorded throughout the examination.
Acquisition time was defined as the arithmetic mean time measured by two independent timekeepers (Yan C and Deng JJ) with standard chronometers (iPhone 6, iOS 10.0; Apple, Inc., Cupertino, Calif., USA). In each examination, completed scans were retained for analysis, whereas the uncompleted ones were deleted and repeated. However, when a scan was completed with low signal strength or low-quality [24] , repeat acquisition was not performed, as per study protocol. Each subject was instructed to close their eyes for at least 5min and blink completely before each examination. Image Quality Evaluation Vessel valid visibility evaluation and motion artifacts detection were included in the image quality evaluation. Vessel Valid Visibility Evaluation Vessel valid visibility was defined as the capacity of detecting vessels integrally. To compare the sensitivity of OCTA devices in detecting vessels, a measure independent of scan lateral resolution and scan line number, using MatLab, was proposed [25] [26] . This included calculating the vessel length detected by OCTA devices in a ring shape region of interest (ROI) around the fovea, with outer diameter of 1.00 mm and inner diameter of 0.36 mm for 3×3 mm 2 scan, and with outer diameter of 2.00 mm and inner diameter of 0.72 mm for 6×6 mm 2 scan. The center of fovea was manually specified by a grader. The application of ROI ensured that the area analyzed excluded errors caused by inevitable small position deviations among scans and trademark logos on the edge of images. First, the original angiogram of SRL ( Figure 2A ) was enhanced using a two-scale (σ=1 and 2 pixels) Frangi vesselness filter [27] [28] . This filter obtains the vesselness measure ( Figure 2B ) by analyzing eigenvalues of the second-order local structure of the angiogram (Hessian). A global threshold using Otsu's method was then calculated and applied to distinguish vessels (larger than threshold) from noise (smaller than threshold), generating a vessel mask ( Figure 2C ) [29] [30] . Considering the variety of lateral resolution across devices, the vessel diameter detected may be different for different devices, so the vessels were skeletonized ( Figure 2D ), then the total length of connected vessels [longer than 3000/(scan line number); Figure 2E ] in a ring shape ROI ( Figure 2F ) was calculated. Considering the variety of scan line number across devices, the vessel valid visibility measure was proposed as the normalized vessel length (vessel length divided by the scan line number) divided by the normalized ROI area (ROI area divided by scan area). To summarize, the vessel valid visibility was a unitless number of ratio between 0 and 1, in which larger values indicated a stronger ability to detect vessels at high quality. Motion Artifacts Detection To detect the motion artifacts, correlation of neighbor B-scan lines were calculated as previously described [22] . As motion artifact goes across all layers, only those on SRL were calculated. For the original angiographic image of SRL ( Figure 3A ), a plot of the correlation between neighboring B-scan lines was generated ( Figure 3B) . B-scan lines with correlations smaller than 0.4 were counted as motion artifacts ( Figure 3C (Table 3) . DISCUSSION OCTA is one of the most important prospective imaging modalities in ophthalmology of the last few years [2] . It can generate not only cross-sectional OCT images with micrometer-scale depth resolution, but also functional OCT images displayed as en-face angiograms, showing retinal and choroidal vessel function [3, [31] [32] . Despite some limitations in detection of vascular leakage, it frees subjects from a timeconsuming angiography procedure and risks of complications due to invasive conventional angiography [33] [34] . Currently, different OCTA systems built by different manufacturers are employed worldwide. In addition, different hardware and software are applied to achieve the same purpose of visualization of vasculature details [8] . The various systems' agreement and precision evaluation are mandatory for both the clinical practice and research settings. A previous study conducted an evaluation concerning AngioVue and AngioPlex, and differences were found concerning their execution time and motion artifacts [24] . Another study involving AngioVue, AngioPlex, Spectralis OCTA and SS OCT angio demonstrated that their angiograms shared similar vessel density but different motion artifacts level [35] . This study developed innovative and quantitative methods in evaluation of image quality and execution time, as well as aspects of reliability across five OCTA instruments, including AngioVue, AngioPlex, Spectralis OCTA, AngioScan, and SS OCT Angio. In our population of young healthy adults with normal vision, there was poor agreement of measurements among systems, indicating their results are not all interchangeable, and they could not be substituted for the others at this time [36] .
In our study, AngioVue demonstrated the highest vessel valid visibility and least number of motion artifacts for both 3×3 and 6×6 mm 2 scan, which may result from its proper scan pattern.
AngioVue employs the SSADA algorithm. This algorithm splits the spectrum, individual decorrelation images can be averaged, and images with good vessel connectivity and high signal-to-noise can be generated [2] . AngioVue requires two orthogonal scans (x-fast and y-fast) in each acquisition. The MCT software then builds a single volumetric data set, and most motion artifacts and changes in brightness are corrected using MCT and DualTrac tracking technology [20, 37] . AngioVue's performance in vessel valid visibility was remarkable in the 6×6 mm 2 scan group, as vascular details such as macular arch ring can be clearly observed. In the 6×6 mm 2 scan, AngioVue has the most intensive A-scan count in both horizontal and vertical directions (400×400), and the distance interval between scan lines accords with speckle diameter, achieving a perfect balance between image quality and scan efficiency. However, with the employment of MCT and DuralTrac, AngioVue sacrifices its performance in terms of acquisition, saving, and analysis time. AngioPlex showed its advantage in acquisition time for both 3×3 and 6×6 mm 2 scan, in comparison with other devices. The algorithm of OMAG is applied in AngioPlex, and it extracts both phase and magnitude signal algorithm from retinal blood flow with better efficacy [7, 38] . The FastTrac retinal-tracking technology can monitor and correct for the motion of the eye in real time. FastTrac ensures faster data acquisition by only rescanning selective data that might be affected by motion. Shorter acquisition time is beneficial for patient comfort, especially for those with dry eyes or poor fixation caused by low visual acuity. Physicians benefit from shorter acquisition time as well. AngioPlex has patented superficial projection elimination technology to reduce projection artifacts. AngioPlex's ganglion cell analysis is another special feature, helpful for patients with glaucoma [23, 39] . Spectralis OCTA can only perform the 3×3 mm 2 scan, not the 6×6 mm 2 scan at the moment of our study. The average number of motion artifacts is only 1.037, as the SMARTTrack technology effectively tracks eye motion, which reduces motion artifacts. Spectralis OCTA is one of the components of the multimodal imaging system based on the Spectralis OCT2. Its OCT angiogram or structural OCT images can overlay on MultiColor or IR images at the same position on the retina, and traditional fluorescein and indocyanine green angiography could be performed as well on a single device. Spectralis OCTA segments SRL and DRL into two "sub-layers". It segments SRL as one sub-layer within the retinal nerve fiber layer (RNFL) and the other within ganglion cell layer (GCL). DRL is divided into sub-layer ranges of IPL to INL and INL to OPL. This segmentation setting fit with retinal vascular network anatomy [13] . AngioScan uses complex difference as its algorithm, and as previously discussed, it is an algorithm based on both phase and magnitude signals of retinal blood flow. Previous studies revealed AngioScan's outstanding data computation abilities, demonstrated as lower computational cost, indicating its practicability [7, 14] . It should also be mentioned that our result may also relate to selected scan pattern, as AngioScan4 contains less data than AngioScan8 mode. SS OCT Angio is a commercially available OCTA device using swept-source optical source [11] . It utilizes a tunable laser with a wavelength of 1050 nm, much longer than that of other OCTA devices. The longer wavelength reduces scattering and absorption of the RPE, allowing for deeper penetration of light into the choroid, increasing possibility of visualization of the whole choroid, or even the sclera [40] [41] . The scan line of SS OCT Angio is quasi invisible, which greatly improves patient comfort. Furthermore, with a scan speed of 100 000 A-scans per second, SS-OCTA has the potential to perform better than SD-OCTA, and several studies already supported this argument [42] [43] [44] [45] . Convincing methodology was applied in our study. All measurements were evaluated quantitatively, so the results are less subjective than some qualitative methods. For image quality evaluation, vessel valid visibility, and number of motion artifacts evaluation, all thresholds remained consistent throughout all subjects for all devices, demonstrating that the results of our comparison were not influenced by personal preference. For acquisition time evaluation, arithmetic means measured by two timekeepers were evaluated, in order to minimize random error. It should be mentioned that for an OCTA system with fixed technical parameters, it takes longer acquisition time to get a higher quality image and vice versa. In our study, AngioVue, AngioPlex, and SS OCT Angio were applied with most intensive A-scans possible, while Spectralis OCTA and AngioScan not because the latter two systems require much longer acquisition. In this assessment, we chose the most frequently used scan patterns in our clinical practice. These quantitative methods could not only be applied on current version of OCTA, but also be valid following the next software update. Vessel valid visibility refers to the capacity of detecting vessels integrally. Retinal vasculature impairment and microvascular abnormalities could be found in common diseases such as branch retinal vein occlusion (BRVO) and diabetic retinopathy (DR), and sensible vessel detection with high image quality lays a foundation in determining treatment and follow-up plans for physicians. SRL is the ideal layer to conduct this evaluation for several reasons. First, it has the least variation in layer segmentation definition comparing to other layers. Second, blood in this layer flows vertically to the scan's optical source and parallel to displayed angiograms, so we can observe distinct retinal superficial capillaries on SRL. This makes several deviation removal procedures, such as skeletonization possible. Third, projection artifact, the falsepositive blood flow signal, is absent on SRL according to its definition. Fourth, foveal avascular zone (FAZ) is the perfect reference point to locate the center of ROI. Although all scans are centered on the macula, small position deviation due to eye motion is still inevitable. Using this device, the largest possible circle in the fovea that did not include any vessels can be manually drawn, and the center of this circle is then used as the fovea center and the center of ROI. This method reduced the variation in specifying fovea center across systems, which is essential for an objective comparison. Moreover, as images were focused on the macula, ROI is the region less affected generally has lower scan density than 3×3 mm 2 scans, larger diameters were used (inner and outer diameters as 0.72 and 2.00 mm). It should be noticed that small variations of those diameter settings did not affect the results significantly. In order to eliminate the noise, which appears as high signal irregular dots, Otsu's method was applied, and it could not only distinguish vessels from noise, but also remove poorly detected vessels with low continuity from calculation [28, [46] [47] . To avoid the influence originated from different systems intrinsic properties, for instance the lateral resolution determined by the number of B-scan, angiograms were skeletonized in our study. Motion artifacts originate from eye motion and failure of software technique removal. Since they contain a collection of pixels with abnormal signal intensity, inaccuracies can be introduced during qualitative and quantitative evaluation of clinically useful parameters. Motion artifacts appear as linear defects on an angiographic image. Some appear as false signals with intensity randomly allocated between maximal and minimal, while others appear as vessel malposition. Though motion artifacts go across all layers in the same B-scan line, SRL is the most sensitive layer to locate them, as it appears as tubular continuous vessels. Their correlation between neighboring B-scan lines is low, which makes automated motion artifacts count possible [5, 19, 22] . The threshold of correlation can range from 0 to 1, and correlations lower than the threshold was considered to be motion artifacts. It is obvious to find that as the value of threshold increases, the sensitivity of detection decreases, and the specificity increases. As long as the threshold is less than 1, there is an inevitable possibility of visible motion artifacts not included in the count, so it is vital to set an equal threshold for all devices. In this study, 0.4 was set empirically as the global threshold, as sensitivity and specificity are balanced using this value. Acquisition time reflects both hardware and software efficiency integrally. Lower acquisition time largely facilitates image acquisition for patients with difficulties in vision fixation due to dry eye or poor vision and improves satisfactions for both participants and physicians. Hardware outside OCT devices like hard drive capacity and graphics properties could also influence it, but there are minimal differences across different OCTA unit with the same model and software version. As such, acquisition time could still be a representative parameter and represent objective systems performances in real world. This current study has several limitations. Due to the nature of our subject selection, our subjects were relatively young and had good visual acuity. Our study aims to compare the clinical performance of five OCTA systems, and this population was selected as they provide the best and steadiest compliance. There are other OCTA systems which were not evaluated in this study, such as Angio eXpert of Canon and the SOCT Copernicus REVO of Optopol. In this study, aspects of precision of the five devices such as intraobserver repeatability or intersession reproducibility, were not compared. This is the subject of an ongoing study. Moreover, in this population, other image defects like artifacts caused by media opacity, stretch artifacts, and segmentation defects are unlikely to be seen [5] . Further investigation is needed to compare clinical performance on these five systems in patients with poor vision caused by retinal vascular diseases and older age.
In conclusion, the findings of this study have significant implications. AngioVue, AngioPlex, Spectralis OCTA, AngioScan, and SS OCT Angio are all useful imaging devices and can be easily performed in clinical practice. All of them have their own advantage. AngioVue has outperformed others in image quality, as vessels are visualized in detail with less interference. AngioPlex required the shortest time in data acquisition, leading to more satisfied participants. Spectralis OCTA is part of the multimodal imaging unit, facilitating comparison of different examinations on the exact same position of retina. AngioScan displayed its advantages in its algorithm. SS OCT Angio, a commercially available SS-OCTA, greatly improves patients' comfort. The quantitative methods used in this study are innovative and objective. They can be applied to the evaluation of future OCTA systems as well.
